GLP-1 Weight Loss

Semaglutide (Ozempic® Wegovy) and Tirzepatide (Mounjaro® Zepbound®): Innovative Treatments for Weight Loss and Type 2 Diabetes

In recent years, Semaglutide and Tirzepatide have emerged as groundbreaking medications ir the management of type 2 diabetes and weight loss. Both medications offer patients new hope with their ability to significantly improve blood sugar control and promote weight loss. Here’s what you need to know about each treatment:

Semaglutide: What Is It?

Semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1) that mimics the action of a naturally occurring hormone in the body. It works by increasing insulin release when blood sugar is elevated, slowing gastric emptying (helping you feel fuller longer), and reducing appetite. This combination makes it effective for both managing type 2 diabetes and aiding in weight loss.

How Semaglutide Works:

• Improves Insulin Sensitivity: Semaglutide enhances the pancreas’s ability to release insulin after meals, helping to lower blood sugar levels.
• Suppresses Appetite: It works on the brain’s appetite control centers, reducing hunger and promoting feelings of fullness.
• Slows Gastric Emptying: By slowing down how quickly food moves through your stomach, semaglutide helps you feel full longer, which can help with weight loss.